On Friday, Guggenheim analysts revised their price target for Eli Lilly (NYSE:LLY) shares, reducing it to $973.00 from the previous $995.00, while reiterating a Buy rating on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback